Metabolic syndrome, HOMA-IR and adiponectin in obese adolescents: Metabolic syndrome, HOMA-IR and adiponectin in obese adolescents

Nur Aisiyah Widjaja; Rendi Aji Prihaningtyas; Meta Herdiana Hanindita; Retno Handajani; I Dewa Gede Ugrasena

doi:10.59747/smjidisurabaya.v1i1.5

Penulis

Nur Aisiyah Widjaja Child Health Department, Faculty of Medicine Universitas Airlangga, Indonesia
Rendi Aji Prihaningtyas Child Health Department, Faculty of Medicine Universitas Airlangga, Indonesia https://orcid.org/0000-0002-7582-7892
Meta Herdiana Hanindita Child Health Department, Faculty of Medicine Universitas Airlangga, Indonesia
Retno Handajani Medical Biochemistry Department, Faculty of Medicine Universitas Airlangga, Indonesia
I Dewa Gede Ugrasena Child Health Department, Faculty of Medicine Universitas Airlangga, Indonesia

DOI:

https://doi.org/10.59747/smjidisurabaya.v1i1.5

Kata Kunci:

adiponectin, HOMA-IR, metabolic syndrome, obesity

Abstrak

Background: Homeostasis model assessment (HOMA) is a method used to measure insulin resistance (IR). Adiponectin is involved in the development of atherosclerosis. Objectives: This study aimed to assess metabolic syndrome (MetS) prevalence in adolescents with obesity; correlate HOMA-IR and IR incidence with MetS biochemical parameters and MetS components; as well as correlate adiponectin levels and hypoadiponectinemia incidence with MetS biochemical parameters and MetS components. Methods: This study was conducted at the Outpatient Installation Unit of Nutrition and Metabolic Diseases, Child Health Department, Dr. Soetomo General District Hospital, Surabaya, Indonesia with a cross-sectional study design. It lasted for nine months and focused on obese adolescents aged 13-18 years. Anthropometric measurements and blood biochemistry analyses were done. HOMA-IR was calculated using the formula [glucose (mg/dL) x Insulin (µu/L)]/405. Results: A total of 216 obese adolescents took part in the study. MetS was found in 81 subjects (37.96%). There was weak correlation between HOMA-IR with anthropometric measurements, lipid profiles, fasting blood glucose, and serum adiponectin levels (p<0.05). IR was found to increase the risk of MetS development by 1.661-times, dyslipidemia by 1.845-times, and abdominal obesity by 3.077-times. IR increased the risk of MetS incidence with more than three IDF criteria by 9.368-times. There was a correlation between adiponectin levels with the HDL-c. Hypoadiponectinemia was correlated with the incidence of MetS, abdominal obesity, and hypertriglyceridemia. It also increased the risk of developing MetS by 2.220-times. There was a positive relationship between IR HOMA value and the anthropometric parameters of obesity and MetS parameters. Conclusions: IR was found to be associated with dyslipidemia, abdominal obesity, and MetS incidence with more than three IDF criteria. There was a relationship between hypoadiponectinemia and waist circumference, hip circumference, HDL-c, and triglycerides. Insulin resistance and hypoadiponectinemia were associated with Mets and hypertriglyceridemia incidence.

Referensi

Al-Hamad, D., Raman, V., 2017. Metabolic syndrome in children and adolescents. Transl. Pediatr. 6(4):397–407. doi:10.21037/tp.2017.10.02

Baratta, R., Amato, S., Degano, C., Farina, M.G., Patanè, G., Vigneri, R., Frittitta, L., 2004. Adiponectin relationship with lipid metabolism is independent of body fat mass: Evidence from both cross-sectional and intervention studies. J. Clin. Endocrinol. Metab. 89(6):2665–2671. doi: 10.1210/jc.2003-031777.

Bazanelli, A.P., Kamimura, M.A., Canziani, M.E.F., Manfredi, S.R., Cuppari, L., 2013. Waist circumference as a predictor of adiponectin levels in peritoneal dialysis patients: A 12-month follow-up study. Perit. Dial. Int. 33(2):182–188. doi: 10.3747/pdi.2011.00129.

Blaslov, K., Bulum, T., Zibar, K., Duvnjak, L., 2013. Relationship between adiponectin level, insulin sensitivity, and metabolic syndrome in type 1 diabetic patients. Int. J. Endocrinol. 2013, 1–7. doi:10.1155/2013/535906.

Borai, A., Livingstone, C., Ferns, G.A.A., 2007. The biochemical assessment of insulin resistance. Ann. Clin. Biochem. 44(Pt 4):324–342. doi: 10.1258/000456307780945778.

Brady, T.M., 2017. Obesity-related hypertension in children. Front. Pediatr. 5:197. doi: 10.3389/fped.2017.00197.

Brambilla, P., Antolini, L., Street, M.E., Giussani, M., Galbiati, S., Valsecchi, M.G., Stella, A., Zuccotti, G.V., Bernasconi, S., Genovesi, S., 2013. Adiponectin and hypertension in normal-weight and obese children. Am. J. Hypertens. 26(2):257–264. doi: 10.1093/ajh/hps033.

Brewer, P.D., Habtemichael, E.N., Romenskaia, I., Mastick, C.C., Coster, A.C.F., 2014. Insulin-regulated Glut4 translocation: Membrane protein trafficking with six distinctive steps. J. Biol. Chem. 289(25):17280–17298. doi: 10.1074/jbc.M114.555714.

Bryman, A., Cramer, D., 2002. Quantitative Data Analysis with SPSS Release 10 for Windows A guide for social scientists, Quantitative Data Analysis with SPSS Release 8 for Windows. Routledge: UK

Caceres, M., Teran, C.G., Rodriguez, S., Medina, M., 2008. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity. BMC Pediatr. 8:1–6. doi: 10.1186/1471-2431-8-31.

Castro, A.M., Macedo-de la Concha, L.E., Pantoja-Meléndez, C.A., 2017. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Rev. Médica del Hosp. Gen. México 80(2):101–105. doi: 10.1016/j.hgmx.2016.06.011.

Cat, A.N.D., Friederich-Persson, M., White, A., Touyz, R.M., 2016. Adipocytes, aldosterone and obesity-related hypertension. J. Mol. Endocrinol. 57(1):F7–F21. doi: 10.1530/JME-16-0025.

Cerf, M.E., 2013. Beta cell dysfunction and insulin resistance. Front. Endocrinol. (Lausanne). 4:37. doi: 10.3389/fendo.2013.00037.

Cho, J., Hong, H., Park, S., Kim, S., Kang, H., 2017. Insulin resistance and its association with metabolic syndrome in Korean children. Biomed Res. Int. 2017:8728017. doi: 10.1155/2017/8728017.

Chow, W.S., Cheung, B.M.Y., Tso, A.W.K., Xu, A., Wat, N.M.S., Fong, C.H.Y., Ong, L.H.Y., Tam, S., Tan, K.C.B., Janus, E.D., Lam, T.H., Lam, K.S.L., 2007. Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective study. Hypertension 49, 1455–1461. doi: 10.1161/HYPERTENSIONAHA.107.086835.

Cnop, M., Havel, P.J., Utzschneider, K.M., Carr, D.B., Sinha, M.K., Boyko, E.J., Retzlaff, B.M., Knopp, R.H., Brunzell, J.D., Kahn, S.E., 2003. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 46(4):459–469. doi: 10.1007/s00125-003-1074-z.

Di Chiara, T., Argano, C., Corrao, S., Scaglione, R., Licata, G., 2012. Hypoadiponectinemia: A link between visceral obesity and metabolic syndrome. J. Nutr. Metab. 2012:175245. doi: 10.1155/2012/175245.

Draznin, B., 2006. Molecular mechanisms of insulin resistance: Serine phosphorylation of insulin receptor substrate-1 and increased expression of p85 α: The two sides of a coin. Diabetes 55(8):2392–2397. doi: 10.2337/db06-0391.

Falkner, B., 2017. Monitoring and management of hypertension with obesity in adolescents. Integr. Blood Press. Control 10, 33–39. doi: 10.2147/IBPC.S125094.

Falkner, B., Cossrow, N.D.F.H., 2014. Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States. Curr. Hypertens. Rep. 16(7):1–15. doi: 10.1007/s11906-014-0449-5.

Gao, H., Fall, T., Van Dam, R.M., Flyvbjerg, A., Zethelius, B., Ingelsson, E., Hägg, S., 2013. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: A mendelian randomization study. Diabetes 62(4):1338–1344. doi: 10.2337/db12-0935.

Gilardini, L., McTernan, P.G., Girola, A., da Silva, N.F., Alberti, L., Kumar, S., Invitti, C., 2006. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 189(2):401–407. doi: 10.1016/j.atherosclerosis.2005.12.021.

González, M., Del Mar Bibiloni, M., Pons, A., Llompart, I., Tur, J.A., 2012. Inflammatory markers and metabolic syndrome among adolescents. Eur. J. Clin. Nutr. 66(10):1141–1145. doi: 10.1038/ejcn.2012.112.

Greenberg, A.S., Obin, M.S., 2006. Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 83(2):461–465. doi: 10.1093/ajcn/83.2.461S.

Hardy, O.T., Czech, M.P., Corvera, S., 2012. What causes the insulin resistance underlying obesity? Curr. Opin. Endocrinol. Diabetes Obes. 19(2):81–87. doi: 10.1097/MED.0b013e3283514e13.

Hsu, C.H., 2013. Different impacts of metabolic syndrome components on insulin resistance in type 2 diabetes. Int. J. Endocrinol. 2013: 740419 | https://doi.org/10.1155/2013/740419.

Isa, N.F., Zainuddin, L.R.M., Wan Muda, W.M., Mohamed, H.J.B.J., 2017. Association of Serum Adiponectin Levels with Metabolic Syndrome Risk Factors in Malay Adults. World Nutr. J. 1(1):17. doi: 10.25220/WNJ.V01i1.0005.

Jalilolghadr, S., Javadi, A., Mahram, M., Farshidgohar, M., Javadi, M., 2015. Prevalence of metabolic syndrome and insulin resistance in children and adolescent of Qazvin, Iran. Malaysian J. Med. Sci. 22(6):32–39.

Kern, P.A., Di Gregorio, G.B., Lu, T., Rassouli, N., Ranganathan, G., 2003. Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52(7):1779–1785. doi: 10.2337/diabetes.52.7.1779.

Klein, D.J., Friedman, L.A., Harlan, W.R., Barton, B.A., Schreiber, G.B., Cohen, R.M., Harlan, L.C., Morrison, J.A., 2004. Obesity and the Development of Insulin Resistance and Impaired Fasting Glucose in Black and White Adolescent Girls: A longitudinal study. Diabetes Care 27(2):378–383. doi: 10.2337/diacare.27.2.378.

Klop, B., Elte, J.W.F., Cabezas, M.C., 2013. Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients 5(4):1218–1240. doi:10.3390/nu5041218.

Lee, L., Sanders, R.A., 2012. Metabolic syndrome. Pediatr. Rev. 33(10):549–468. doi: 10.1542/pir.33-10-459.

Lentferink, Y.E., Elst, M.A.J., Knibbe, C.A.J., Van Der Vorst, M.M.J., 2017. Predictors of Insulin Resistance in Children versus Adolescents with Obesity. J. Obes. 2017:3793868. doi: 10.1155/2017/3793868.

Li, H.Y., Chiu, Y.F., Hwu, C.M., Sheu, W.H.H., Hung, Y.J., Fujimoto, W., Quertermous, T., Curb, J.D., Tai, T.Y., Chuang, L.M., 2008. The negative correlation between plasma adiponectin and blood pressure depends on obesity: A family-based association study in SAPPHIRe. Am. J. Hypertens. 21(4):471–476. doi: 10.1038/ajh.2008.5

Ling, J.C.Y., Mohamed, M.N.A., Jalaludin, M.Y., Rampal, S., Zaharan, N.L., Mohamed, Z., 2016. Determinants of High Fasting Insulin and Insulin Resistance among Overweight/Obese Adolescents. Sci. Rep. 6:36270. doi: 10.1038/srep36270.

Magge, S.N., Goodman, E., Armstrong, S.C., COMMITTEE ON NUTRITION; SECTION ON ENDOCRINOLOGY; SECTION ON OBESITY. 2017. The Metabolic Syndrome in Children and Adolescents: Shifting the Focus to Cardiometabolic Risk Factor Clustering CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care. From Am. Acad. Pediatr. Pediatr. 140(2):e20171603. doi: 10.1542/peds.2017-1603

Masquio, D.C.L., Ganen, A. de P., Campos, R.M. da S., Sanches, P. de L., Corgosinho, F.C., Caranti, D., Tock, L., de Mello, M.T., Tufik, S., Dâmaso, A.R., 2015. Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents. Nutr. Hosp. 31(4):1540-1550. doi:10.3305/nh.2015.31.4.8442.

Matsuzawa, Y., Funahashi, T., Kihara, S., Shimomura, I., 2004. Adiponectin and Metabolic Syndrome. Arterioscler. Thromb. Vasc. Biol. 24(1):29–33. doi: 10.1161/01.ATV.0000099786.99623.EF.

Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. doi: 10.1007/BF00280883.

Mori, Y., Hoshino, K., Yokota, K., Itoh, Y., Tajima, N., 2006. Role of hypoadiponectinemia in the metabolic syndrome and its association with post-glucose challenge hyper-free fatty acidemia: A study in prediabetic Japanese males. Endocrine 29(2):357–361. doi: 10.1385/ENDO:29:2:357.

Murguía-Romero, M., Jiménez-Flores, R., Villalobos-Molina, R., Méndez-Cruz, A.R., 2012. Estimating the geographical distribution of the prevalence of the metabolic syndrome in young Mexicans. Geospat. Health 6(3):42–50. doi: 10.4081/gh.2012.121.

Must, A., Spadano, J., Coakley, E.H., Field, A.E., Colditz, G., Dietz, W.H., 1999. The disease burden associated with overweight and obesity. J. Am. Med. Assoc. 282(16):1523–1529. doi: 10.1001/jama.282.16.1523.

Ogawa, Y., Kikuchi, T., Nagasaki, K., Hiura, M., Tanaka, Y., Uchiyama, M., 2005. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens. Res. 28(1):51–57. doi: 10.1291/hypres.28.51.

Park, J., Hilmers, D.C., Mendoza, J.A., Stuff, J.E., Liu, Y., Nicklas, T.A., 2010. Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: Comparison between the United States and Korea. J. Korean Med. Sci. 25(1):75–82. doi: 10.3346/jkms.2010.25.1.75.

Pulungan, A.B., Puspitadewi, A., Sekartini, R., 2013. Prevalence of insulin resistance in obese adolescents. Paediatr. Indones. 53(3):167. doi: 10.14238/pi53.3.2013.167-72.

Pyrzak, B., Ruminska, M., Popko, K., Demkow, U., 2010. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur. J. Med. Res. 15 Suppl 2 (Suppl 2), 147–51. doi: 10.1186/2047-783x-15-s2-147.

Ravussin, E., Smith, S.R., 2015. Role of the Adipocyte in Metabolism and Endocrine Function, Seventh Ed. ed, Endocrinology: Adult and Pediatric. Elsevier Inc: Amsterdam

Rothstein, H.R., 1992. Meta-Analysis and Construct Validity. Hum. Perform. 5(1-2):71–80. doi: 10.1080/08959285.1992.9667925.

Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y., Funahashi, T., 2004. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Circ. J. 68(11):975–981. doi: 10.1253/circj.68.975.

Savage, D.B., Petersen, K.F., Shulman, G.I., 2007. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87(2):507–520. doi: 10.1152/physrev.00024.2006.

Sewaybricker, L.E., Ângela, M., Antonio, R.G.M., Mendes, R.T., De Azevedo, A., Filho, B., Zambon, M.P., 2013. Metabolic syndrome in obese adolescents: what is enough? Rev Assoc Med Bras 59(1):64–71. doi: 10.1016/S2255-4823(13)70431-4

Shafiee, G., Ahadi, Z., Qorbani, M., Kelishadi, R., Ziauddin, H., Larijani, B., Heshmat, R., 2015. Association of adiponectin and metabolic syndrome in adolescents: The caspian- III study. J. Diabetes Metab. Disord. 14:89. doi: 10.1186/s40200-015-0220-8.

Singh, B., 2010. Surrogate markers of insulin resistance: A review. World J. Diabetes 1(2):36-47. doi: 10.4239/wjd.v1.i2.36.

Singh, Y., Garg, M.K., Tandon, N., Marwaha, R.K., 2013. A Study of Insulin Resistance by HOMA-IR and its Cut-off Value to Identify Metabolic Syndrome in Urban Indian Adolescents. J. Clin. Res. Pediatr. Endocrinol. 5(4):245–251. doi: 10.4274/Jcrpe.1127.

Sorof, J., Daniels, S., 2002. Obesity hypertension in children: A problem of epidemic proportions. Hypertension 40(4):441–447. doi: 10.1161/01.hyp.0000032940.33466.12.

Sparrenberger, K., Sbaraini, M., Cureau, F.V., Teló, G.H., Bahia, L., Schaan, B.D., 2019. Higher adiponectin concentrations are associated with reduced metabolic syndrome risk independently of weight status in Brazilian adolescents. Diabetol. Metab. Syndr. 11:40. doi: 10.1186/s13098-019-0435-9.

Steinberger, J., Daniels, S.R., 2003. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: An American heart association scientific statement from the atherosclerosis, hypertension, and obesity in the young committee (council on cardiovascular disease in the young) and the Diabetes Committee (council on nutrition, physical activity, and metabolism). Circulation. 107(10):1448–1453. doi: 10.1161/01.cir.0000060923.07573.f2.

Tsai, J.P., Liu, H.M., Lee, C.J., Chang, H.R., Hsu, B.G., 2011. Hypoadiponectinemia is associated with metabolic syndrome in hemodialysis patients. Tzu Chi Med. J. 23(3):77–81. doi: 10.1016/j.tcmj.2011.06.003.

Weiss, R., Dziura, J., Burgert, T.S., Tamborlane, W. V., Taksali, S.E., Yeckel, C.W., Allen, K., Lopes, M., Savoye, M., Morrison, J., Sherwin, R.S., Caprio, S., 2004. The metabolic syndrome in children and adolescents. N. Engl. J. Med. 350(23):262–2374. doi: 10.1056/NEJMoa031049.

Zatterale, F., Longo, M., Naderi, J., Raciti, G.A., Desiderio, A., Miele, C., Beguinot, F., 2020. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front. Physiol. 10:1607. doi: 10.3389/fphys.2019.01607.

Zhang, H.H., Souza, S.C., Muliro, K. V., Kraemer, F.B., Obin, M.S., Greenberg, A.S., 2003. Lipase-selective Functional Domains of Perilipin A Differentially Regulate Constitutive and Protein Kinase A-stimulated Lipolysis. J. Biol. Chem. 278(51):51535–51542. doi: 10.1074/jbc.M309591200.

Zimmet, P., Alberti, G., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S., 2007a. The metabolic syndrome in children and adolescents. Lancet 369(9579):2059–2061. doi: 10.1016/S0140-6736(07)60958-1.

Zimmet, P., Alberti, G.K.M.M., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S., 2007b. The metabolic syndrome in children and adolescents - An IDF consensus report. Pediatr. Diabetes 8(5):299–306. doi: 10.1111/j.1399-5448.2007.00271.x

Metabolic syndrome, HOMA-IR and adiponectin in obese adolescents